🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Healthcare Sector SEC Filings — August 07, 2026

The 18 filings for the S&P 500 Healthcare sector reveal a period of significant insider selling by top executives, particularly at Merck, Johnson & Johnson, and Thermo Fisher Scientific, which may signal caution at current valuation levels. While institutional investors like State Street maintain large passive stakes in UnitedHealth, BD, and Bristol-Myers Squibb, the insider activity is overwhelmingly bearish, with multiple C-suite officers selling shares. No major period-over-period trends or forward-looking guidance changes were reported in these filings, but the concentration of insider sales across several large-cap names suggests a sector-wide sentiment of profit-taking or hedging. The lone bright spot is a director purchase at Boston Scientific, which could indicate confidence in the medical device sub-sector. Overall, the digest points to a cautious outlook for large-cap pharma and biotech, with potential opportunities in undervalued medical device and managed care names.

14 high priority 4 medium 18 total filings
· daily

US Earnings Financial Results SEC Filings — August 07, 2026

The 50 filings for the period ending June 30, 2026, reveal a market characterized by a 'growth vs. profitability' tension. While many companies report top-line expansion (e.g., Monster Beverage +20.2%, Natera +37.7%, Willdan +33%), a significant number are experiencing margin compression or outright profit declines due to rising operating costs, higher interest expenses, and non-recurring charges. The financial sector shows mixed results with improving net interest margins at BancFirst and Hancock Whitney, but offset by higher provisions and securities losses. A notable theme is the aggressive capital allocation towards acquisitions (Gray Media $264M, Willdan $50.5M) and share buybacks (Maplebear $683M, Republic Services $659M), often funded by debt or depleting cash reserves. The crypto and commodity ETFs are under severe pressure from price declines, while the healthcare and industrial services sectors show pockets of strong turnaround performance (AMN Healthcare, StandardAero). Overall, the data suggests a cautious market where operational discipline and strategic capital deployment are key differentiators, with several companies burning cash to fund growth or shareholder returns, raising sustainability questions. Insider trading activity is notably absent from the enriched data, limiting conviction signals from management, but forward-looking statements and guidance changes are critical to monitor for future direction.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 07, 2026

The eight proxy filings for the 2026 annual meeting season reveal a bifurcated market: several companies are pursuing aggressive capital structure actions (reverse stock splits, asset sales, and business combination extensions) to address liquidity or strategic challenges, while others are focused on routine governance and first-time public company processes. Period-over-period comparisons are limited in these filings, but the prevalence of shareholder votes on transformative transactions (Identiv's asset sale, Future Vision II's extension, Canopy Growth's reverse split) signals a high level of corporate restructuring activity. Insider trading data is sparse, but the Bleichroeder Holders' voting agreement at Identiv and the Sponsor's commitment to fund monthly extensions at Future Vision II provide key signals of insider conviction. The most critical development is the potential liquidation of Future Vision II if the extension fails, and the potential for significant shareholder dilution at Canopy Growth and Pasithea Therapeutics. Overall, the digest highlights a market where governance actions are directly tied to corporate survival and value realization, demanding active monitoring.

8 high priority 8 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 07, 2026

The August 7, 2026 IPO pipeline is dominated by early-stage and high-risk filings, with 5 out of 10 filings representing blank-check companies (SPACs) or pre-revenue entities, signaling a surge in speculative capital formation. A critical theme is the prevalence of dilutive structures: My Size, Inc.'s ELOC agreement and Veradermics' resale offering of 40.6% of outstanding shares highlight significant shareholder dilution risks. The Fox Corp-Roku S-4 merger stands out as the sole high-quality, actionable event, offering a unique arbitrage opportunity with a fixed exchange ratio and cash component. Period-over-period data is sparse across filings, but insider activity and forward-looking statements reveal a cautious sentiment, with multiple companies facing Nasdaq delisting risks and needing substantial funding. The overall pipeline suggests a bifurcated market: high-risk SPACs and pre-revenue biotechs seeking capital, versus a transformative media merger with clear valuation metrics.

10 high priority 10 total filings
· daily

US SEC Trading Suspension Halt Orders — August 07, 2026

The nine filings from August 7, 2026, paint a stark picture of distress among small-cap Nasdaq-listed companies, with a wave of trading suspension and delisting risks triggered by non-compliance with listing standards. The dominant theme is a liquidity and valuation crisis, as 7 out of 9 companies received deficiency notices for failing to maintain the $1.00 minimum bid price or the $35 million market value of listed securities (MVLS) threshold. This cluster of failures suggests a broader market rotation away from micro-cap equities, with companies like Barfresh Food Group and HeartSciences facing existential threats from both regulatory non-compliance and leadership transitions. The most critical development is the impending delisting of NusaTrip Inc., which, combined with its majority owner's bankruptcy, signals a complete loss of investor confidence. While Triller Group Inc. provides a rare positive signal by regaining compliance, the retained jurisdiction by Nasdaq indicates ongoing fragility. The lack of any insider buying across these distressed filings and the absence of positive forward-looking guidance underscore a pervasive bearish sentiment, making this a high-risk environment for investors holding these names. The aggregate data reveals a sector-wide crisis of confidence in micro-cap valuations, with no clear catalyst for reversal other than potentially dilutive reverse stock splits.

9 high priority 9 total filings
· daily

US Executive Officer Management Changes SEC — August 07, 2026

The August 7, 2026, executive and director change filings reveal a market in transition, with an orderly, long-planned CEO succession at Newmark Group standing in stark contrast to a sudden, unexplained CEO departure at Lightbridge Corp. While the majority of filings are routine governance updates (director appointments, retirements, compensation adjustments), the mix of events signals a bifurcated environment: some companies are proactively strengthening boards and succession plans (e.g., AeroVironment, Uranium Royalty Corp), while others face operational risk from execution vulnerabilities (e.g., Gyrodyne, Fusemachines). Notably, shareholder dissent is emerging as a theme, with Apyx Medical and Rocky Mountain Chocolate Factory seeing significant opposition to director elections and compensation plans. Financial results embedded in a few filings highlight extreme performance outliers, with Dorchester Minerals' net income surging 150% YoY, while capital allocation patterns show a shift toward retention and equity-based incentives for retention. The high volume of filings (34 in one day, with 32 new) suggests a busy period for corporate governance activity ahead of the fall earnings season. The most critical developments to watch are the CEO search at Lightbridge and Newmark, the operational risk at Gyrodyne during its liquidation, and the planned succession catalyst at Newmark.

34 high priority 34 total filings
· daily

USA Insider Trading Pulse — August 07, 2026

The August 7, 2026 insider trading pulse reveals a pronounced bearish tilt, with 17 sell-side transactions from C-suite and director-level insiders across a diverse set of sectors, contrasted by only 4 notable buy-side events. The most significant insider sales include the CEO of BayFirst Financial Corp. unloading 148,564 shares, the CFO of Alliance Laundry Holdings selling 15,400 shares after a low-cost exercise, and the CRO of Donegal Group selling 18,000 shares. While many sales were executed under Rule 10b5-1 plans, suggesting pre-planned diversification, the sheer volume and concentration in financials and industrials warrant caution. On the buy side, the CEO of HWH International acquired 320,000 shares, and a 10% owner of Donegal Mutual Insurance matched the CRO's sale with an equivalent purchase, creating a mixed signal. A notable cluster of director stock awards at Allegro Microsystems and Regency Centers Corp. indicates routine compensation, not conviction. The absence of forward-looking guidance changes in this batch limits catalyst visibility, but the insider activity pattern points to potential sector rotation out of financials and into select value plays.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 07, 2026

The August 7, 2026 filings reveal a dynamic M&A landscape with significant strategic divestitures and acquisitions, particularly in the food service and energy sectors. Yum! Brands' $2.7 billion Pizza Hut divestiture (including the $1.2 billion sale to Yum China) is a landmark deal, with Yum China expecting mid-single-digit EPS accretion by 2027-2028 and margin expansion from eliminating the 3% license fee. Plains All American's $1.6 billion Canadian NGL sale to Keyera Corp. drove a 10% YoY Adjusted EBITDA increase and a leverage reduction to 3.3x, while raising organic growth capital guidance. The SPAC sector shows mixed signals: Mercator Acquisition Corp. completed a $172.5 million IPO but faces going concern issues, while Kensington and Silicon Valley Acquisition Corp. advance their business combinations. USA Rare Earth's acquisition of Texas Mineral Resources consolidates the rare earth sector. Insider activity is limited, but the resignation of two executives at Constellation Acquisition Corp I warrants attention. Overall, the period is marked by strategic portfolio reshaping, with companies using divestiture proceeds for debt reduction and growth investments.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 07, 2026

Overnight SEC filings reveal a market dominated by a transformative M&A deal in the homebuilding sector, significant capital expenditure plans in the semiconductor industry, and mixed corporate earnings. The $2.2B acquisition of Beazer Homes by Dream Finders Homes is the standout event, creating the 6th largest US homebuilder and signaling consolidation in the sector. In tech hardware, SK hynix announced massive, long-term investments totaling over $33.7B for new fabrication facilities, underscoring a secular growth trend in memory semiconductors. However, earnings reports from Tenaris, Melco Resorts, and Toyota show margin compression and mixed results, highlighting a challenging operating environment for some industrials and consumer cyclicals. Insider activity was a mixed bag, with notable sales at Meta Platforms and Kaspi.kz, while director awards at New Horizon Aircraft and Liftoff Mobile suggest alignment. The overall theme is one of strategic repositioning through M&A and heavy capex, contrasted with operational headwinds in several key sectors.

19 high priority 31 medium 50 total filings
· daily

DHS Homeland Security Contracts — August 06, 2026

This digest covers a single $121.1 million DHS contract awarded to Leidos in July 2006, now expired. The total obligation is entirely civilian (DHS/USCIS), with no defense exposure. The contract is a cost-plus-award-fee, competitively awarded IT support services delivery order. Given its age and expiration, this contract provides no current revenue stream or forward-looking catalyst. The highest-conviction signal is neutral, reflecting limited actionable insight for investors. Key risk is the lack of recent DHS award data to assess Leidos’s current competitive position in civilian IT services.

1 total filings
· daily

New Federal Contractors — August 06, 2026

The three contracts analyzed total $755.6 million in obligations, with zero defense-related awards, indicating a purely civilian procurement focus for this period. The dominant theme is large-scale, recurring civilian agency spending, led by a $506.5 million Department of Education award to the Pennsylvania Higher Education Assistance Agency (PHEAA) for student loan servicing. While the highest-conviction signal is neutral due to the lack of publicly traded counterparties, the $128 million award to NDChealth Corporation from HHS represents a material civilian health IT opportunity. A key risk is the lack of forward-looking data from the expired $121 million Leidos DHS contract, which provides no current competitive insight.

3 total filings
· daily

Significant Contract Modifications ($10M+) — August 06, 2026

During the period from July 28 to August 6, 2026, three significant contract modifications totaling $755.6 million were awarded, all from civilian agencies with no defense-related contracts. The largest award, a $506.5 million delivery order to the Pennsylvania Higher Education Assistance Agency (PHEAA) from the Department of Education for student loan servicing, dominates the total and signals stable, recurring civilian spending in financial management services. A $128.1 million contract to NDChealth Corporation from HHS for computer-related services highlights continued civilian IT investment. The smallest award, a $121.1 million cost-plus-fee contract to Leidos from DHS for IT engineering support, is historical (2006-2010) and provides limited forward-looking insight. The highest-conviction signal is the PHEAA award, given its size and essential nature, but the lack of defense contracts and the historical nature of the Leidos award temper overall bullishness. A key risk is the expiration of the PHEAA contract in late 2024, which could disrupt revenue streams if not renewed.

3 total filings
· daily

Contract Deobligations Alert — August 06, 2026

This digest covers $755.6 million in total obligations across three contracts, all civilian (0% defense), with the Department of Education accounting for 67% of the total via a single $506.5 million award to the Pennsylvania Higher Education Assistance Agency (PHEAA). The highest-conviction signal is the PHEAA contract out-performing its base value ($591.4M outlays vs. $506.5M base), suggesting strong execution and scope expansion, though the entity is not publicly traded, limiting direct equity impact. The remaining contracts—$128.1M to NDChealth Corporation (HHS) and $121.1M to Leidos (DHS)—offer limited forward-looking insight: the Leidos contract expired in 2010, and NDChealth's details are opaque. Key risk: the PHEAA contract ends November 2024, with recompete uncertainty looming; no contracts show defense alignment, reinforcing a civilian-service theme.

3 total filings
· daily

Contract Option Exercises — August 06, 2026

This digest covers $755.6 million in contract option exercises from August 6, 2026, entirely civilian (0/3 defense-related) and dominated by a single $506.5 million Department of Education award to Pennsylvania Higher Education Assistance Agency (PHEAA) for student loan servicing. The highest-conviction signal is neutral from a materiality perspective, as the largest contract is with a non-public entity, limiting direct equity implications. A $128.1 million HHS award to NDCHEALTH CORPORATION offers potential growth exposure but lacks critical detail on pricing or competitive dynamics. A key risk is the expired $121 million Leidos DHS contract signaling past competitive wins but zero current forward visibility, undermining confidence in sustained DHS IT spending trends.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — August 06, 2026

The digest covers a single, large $128.1 million civilian contract awarded to NDCHEALTH CORPORATION by the Department of Health and Human Services (HHS) for other computer-related services, with no defense-related awards in the period. This award represents a high materiality event for NDCHEALTH, though the lack of competitive or pricing details introduces execution and budget risk. The dominant theme is civilian IT services spending, particularly within HHS, which signals sustained demand for health IT modernization. The highest-conviction signal is the neutral rating due to opaque contract terms, and a key risk is the potential for budget reallocation under a continuing resolution or political shifts affecting HHS discretionary spending.

1 total filings
· daily

All HHS Contracts — August 06, 2026

The single HHS contract in this period, a $128.1M award to NDCHealth Corporation for other computer-related services, is a civilian-sector, non-defense transaction with neutral signal strength. The award is notable for its size and sole-source nature, suggesting a critical dependency on NDCHealth for HHS IT infrastructure. However, the lack of competitive pricing data and the absence of defense-related spending limit the immediate bullish case. Key risks include potential protest vulnerability and execution risk given the fixed-price or cost-plus structure is unknown. Investors should monitor HHS IT modernization priorities and any re-compete triggers.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — August 06, 2026

The three contracts analyzed, totaling $755.6 million, are entirely civilian, with zero defense spending, underscoring a lack of Pentagon exposure in this period. The dominant theme is high-volume, long-duration civilian administrative services, led by a $506.5 million Department of Education loan servicing contract to PHEAA—a state agency, not a public company—limiting direct equity play. A $128.1 million NDCHEALTH Corporation HHS contract offers the highest-conviction signal for health IT exposure, though data is sparse. A 19-year-old expired $121 million Leidos DHS contract provides no forward-looking insight. The key risk is that the largest award has no public-company beneficiary, diluting actionable investment signals.

3 total filings
· daily

High-Value Federal Grants ($5M+) — August 06, 2026

This digest covers $755.6 million in high-value federal grants and contracts, all civilian (0% defense), with an average signal strength of 4.0/10, indicating limited actionable investment insight. The dominant award is a $506.5 million Department of Education delivery order to Pennsylvania Higher Education Assistance Agency (PHEAA) for student loan servicing, but PHEAA is a state government entity, not a publicly traded company, offering no direct equity exposure. A $128.1 million HHS contract to NDChealth Corporation for IT services provides a moderate materiality signal (8/10) but lacks key details on pricing and competition. A $121.1 million expired DHS contract with Leidos, Inc. (2006-2010) offers no forward-looking relevance. The highest-conviction signal is the neutral-to-weak data quality, with no bullish or bearish signals identified. Key risk: the lack of defense contracts and the expired nature of the Leidos award limit sector-specific investment catalysts.

3 total filings